The University of Hong Kong (HKUMed) launches its Medical Artificial Intelligence Laboratory Programme (MAIL) to pilot an artificial intelligence (AI) healthcare research study through a series of innovative and prospective clinical AI trial.
HKU will collaborate with Ping An International Smart City Technology., Ltd. Under this collaboration MAIL will utilize its broad AI expertise and resource to design and execute the clinical trials, recruit patients and perform data analysis for clinical validation and evaluation of the board impact of Ping An’s optimal coherence tomography (OCT) and Fundoscopy AI systems on patient workflow and decision making, reports Mirage News.
AI OCT and Fundoscopy systems are screening and referral systems for eye diseases that employ AI trained on input from clinical experts, with each AI tool capturing important but different clinical information.
By addressing several “firsts” for medical AI studies in the prospective clinical trials focus area, the team will leverage these technologies in novel and unique ways for better understanding of the impact of these AI systems on patient management workflow.
The study runs from May 29, 2019 through April 2020. It will initially involve 500 patients with continuous enrollment of consenting subjects.
Michael D. Kuo, Department of Diagnostic Radiology, HKUMed
Dr. Vince Vardhanabhut, Clinical Assistant Professor of Department of Diagnostic Radiology, HKU Med
Dr. Jasper Won, Clinical Assistant Professor of Department of Ophthalmology